Oriental Carbon [OCCL] vs Chemo-Pharma [CPL] Detailed Stock Comparison

Oriental Carbon & Chemicals Ltd.

NSE
Loading...

Chemo-Pharma Laboratories Inc.

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Oriental Carbon & Chemicals Ltd. wins in 9 metrics, Chemo-Pharma Laboratories Inc. wins in 10 metrics, with 0 ties. Chemo-Pharma Laboratories Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Oriental Carbon & Chemicals Ltd. Chemo-Pharma Laboratories Inc. Better
P/E Ratio (TTM) 77.41 13.22 Chemo-Pharma Laboratories Inc.
Price-to-Book Ratio 0.87 2.69 Oriental Carbon & Chemicals Ltd.
Debt-to-Equity Ratio 0.01 48.02 Oriental Carbon & Chemicals Ltd.
PEG Ratio -1.00 0.42 Chemo-Pharma Laboratories Inc.
EV/EBITDA 10.41 13.60 Oriental Carbon & Chemicals Ltd.
Profit Margin (TTM) 9.67% 6.53% Oriental Carbon & Chemicals Ltd.
Operating Margin (TTM) 18.99% 11.52% Oriental Carbon & Chemicals Ltd.
EBITDA Margin (TTM) 18.99% 11.52% Oriental Carbon & Chemicals Ltd.
Return on Equity 1.17% 20.97% Chemo-Pharma Laboratories Inc.
Return on Assets (TTM) 0.94% 11.26% Chemo-Pharma Laboratories Inc.
Free Cash Flow (TTM) $23.96M $41.66M Chemo-Pharma Laboratories Inc.
Dividend Yield 2.84% N/A N/A
1-Year Return -6.68% -5.34% Chemo-Pharma Laboratories Inc.
Price-to-Sales Ratio (TTM) 2.15 1.31 Chemo-Pharma Laboratories Inc.
Enterprise Value $2.33B $5.40B Chemo-Pharma Laboratories Inc.
EV/Revenue Ratio 2.15 1.52 Chemo-Pharma Laboratories Inc.
Gross Profit Margin (TTM) 41.04% 24.93% Oriental Carbon & Chemicals Ltd.
Revenue per Share (TTM) $108 $62 Oriental Carbon & Chemicals Ltd.
Earnings per Share (Diluted) $3.01 $5.81 Chemo-Pharma Laboratories Inc.
Beta (Stock Volatility) 0.06 0.28 Oriental Carbon & Chemicals Ltd.

Oriental Carbon & Chemicals Ltd. vs Chemo-Pharma Laboratories Inc. Stock Performance Analysis

Loading Price Chart...

OCCL
CPL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Oriental Carbon & Chemicals Ltd.0.00%0.19%-26.15%34.10%39.35%39.35%
Chemo-Pharma Laboratories Inc.0.43%-0.20%-9.72%10.04%-11.06%-12.31%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Oriental Carbon & Chemicals Ltd.-6.68%-72.39%-70.42%-54.26%-54.26%-54.26%
Chemo-Pharma Laboratories Inc.-5.34%232.23%82.57%325.71%1,271.09%1,271.09%

Performance & Financial Health Analysis: Oriental Carbon & Chemicals Ltd. vs Chemo-Pharma Laboratories Inc.

MetricOCCLCPL
Market Information
Market Cap i₹2.33B₹4.62B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i11,97997,700
90 Day Avg. Volume i90,99968,661
Last Close₹233.34₹70.50
52 Week Range₹132.00 - ₹400.00₹52.67 - ₹87.75
% from 52W High-41.67%-19.66%
All-Time High₹1,599.70 (Jan 01, 2018)₹128.00 (Jan 06, 2025)
% from All-Time High-85.41%-44.92%
Growth Metrics
Quarterly Revenue Growth0.89%0.40%
Quarterly Earnings Growth11.88%0.41%
Financial Health
Profit Margin (TTM) i0.10%0.07%
Operating Margin (TTM) i0.19%0.12%
Return on Equity (TTM) i0.01%0.21%
Debt to Equity (MRQ) i0.0148.02
Cash & Liquidity
Book Value per Share (MRQ)₹266.61₹28.58
Cash per Share (MRQ)N/A₹0.05
Operating Cash Flow (TTM) i₹80.93M₹277.99M
Levered Free Cash Flow (TTM) i₹1.11B₹313.23M
Dividends
Last 12-Month Dividend Yield i2.84%N/A
Last 12-Month Dividend i₹7.00₹0.00

Valuation & Enterprise Metrics Analysis: Oriental Carbon & Chemicals Ltd. vs Chemo-Pharma Laboratories Inc.

MetricOCCL (Jul 28, 2025)CPL (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i77.4113.22
Forward P/E i21.18N/A
PEG Ratio i-1.000.42
Price to Sales (TTM) i2.151.31
Price to Book (MRQ) i0.872.69
Market Capitalization
Market Capitalization i₹2.33B₹4.62B
Enterprise Value i₹2.33B₹5.40B
Enterprise Value Metrics
Enterprise to Revenue i2.151.52
Enterprise to EBITDA i10.4113.60
Risk & Other Metrics
Beta i0.060.28
Book Value per Share (MRQ) i₹266.61₹28.58

Financial Statements Comparison: Oriental Carbon & Chemicals Ltd. vs Chemo-Pharma Laboratories Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricOCCL (2025)CPL (2025)
Revenue/Sales i1.08B2.85B
Cost of Goods Sold i591.13M2.07B
COGS % of Revenue i54.6%72.6%
Gross Profit i491.63M778.98M
Gross Margin i45.4%27.4%
Research & Development iN/AN/A
Operating Income (EBIT) i92.18M300.69M
Operating Margin i8.5%10.6%
EBITDA i223.96M353.29M
EBITDA Margin i20.7%12.4%
Pre-Tax Income i109.69M392.47M
Pre-Tax Income % of Revenue i10.1%13.8%
Income Tax i53.49M79.24M
Income Tax % of Revenue i4.9%2.8%
Net Income (Profit) i130.77M313.23M
Profit Margin i12.1%11.0%

Balance Sheet & Liquidity Metrics

MetricOCCL (2025)CPL (2025)
Cash & Equivalents i28.43M12.05M
Total Current Assets i1.26B2.51B
Total Current Assets % of Revenue i116.5%88.1%
Total Current Liabilities i181.37M1.17B
Total Current Liabilities % of Revenue i16.8%41.2%
Long-Term Debt i12.28M109.50M
Long-Term Debt % of Revenue i1.1%3.8%
Total Shareholders Equity i2.96B1.49B
Retained Earnings iN/A1.08B
Retained Earnings % of Revenue i0.0%37.9%
Property, Plant & Equipment i681.78M48.61M

Cash Flow Statement Comparison

MetricOCCL (2025)CPL (2025)
Operating Cash Flow i212.71M277.99M
Operating Cash Flow % of Revenue i19.6%9.8%
Capital Expenditures i-31.21M-47.82M
Free Cash Flow i23.96M41.66M
FCF Margin i2.2%1.5%
Debt Repayment i-229.83M-359.80M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricOCCLCPL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i9.99M60.18M
Float Shares i4.50M17.41M
% Held by Insiders i53.32%69.98%
% Held by Institutions i4.71%0.00%
% Held by Public i41.97%30.02%

Dividend Analysis & Yield Comparison: Oriental Carbon & Chemicals Ltd. vs Chemo-Pharma Laboratories Inc.

MetricOCCLCPL
Last 12-Month Dividend i₹7.00₹0.00
Last 12-Month Dividend Yield i2.84%N/A
3-Year Avg Annual Dividend i₹11.67₹0.00
3-Year Avg Dividend Yield i1.10%N/A
3-Year Total Dividends i₹35.00₹0.00
Ex-Dividend DateJul 23, 2024N/A